Literature DB >> 9703760

The elusive nature of intrinsic efficacy.

W P Clarke1, R A Bond.   

Abstract

In the discipline of pharmacology, drugs (ligands) are used as tools to elucidate the processes of biological systems. Because of this, pharmacologists strive to delineate all characteristics of drugs. Decades of research have resulted in the proposal that ligands possess two properties that are intrinsic to the ligand and are invariant of the system in which their effects are investigated. These properties are affinity (the capacity of a drug to bind to a receptor) and intrinsic efficacy (the capacity of a drug to activate or inactivate a receptor). Although affinity is a relatively easy parameter to measure with a variety of techniques, ways of quantifying intrinsic efficacy have remained elusive ever since its inception. Furthermore, recent evidence suggests that intrinsic efficacy might not be a single, ligand-dependent parameter but that agonists might have multiple intrinsic efficacies. William Clarke and Richard Bond discuss several reasons why the claim that intrinsic efficacy is a ligand-dependent parameter should be questioned, and the possible impact of these findings.

Mesh:

Substances:

Year:  1998        PMID: 9703760     DOI: 10.1016/s0165-6147(97)01138-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  NGF stimulation of erk phosphorylation is impaired by a point mutation in the transmembrane domain of trkA receptor.

Authors:  M Monshipouri; H Jiang; P Lazarovici
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

2.  Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.

Authors:  Aska Hayashi; Masanori Suzuki; Masao Sasamata; Keiji Miyata
Journal:  Psychopharmacology (Berl)       Date:  2004-10-21       Impact factor: 4.530

3.  Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.

Authors:  Philippe Van Rompaey; Kenneth A Jacobson; Ariel S Gross; Zhan-Guo Gao; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2005-02-15       Impact factor: 3.641

4.  Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.

Authors:  Soo-Kyung Kim; Zhan-Guo Gao; Lak Shin Jeong; Kenneth A Jacobson
Journal:  J Mol Graph Model       Date:  2006-05-09       Impact factor: 2.518

Review 5.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

6.  Analysis of the atypical characteristics of adenosine receptors mediating negative inotropic and chronotropic responses of guinea-pig isolated atria and papillary muscles.

Authors:  N M Gardner; K J Broadley
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 7.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions.

Authors:  Ivan Marchionni; Michael Beaumont; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

9.  The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

10.  Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.

Authors:  Radhika Joshi; Daniel Valdez; Hosu Kim; Douglas C Eikenburg; Brian J Knoll; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2017-07-17       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.